July 8, 2026 · Acquisition
CMMB Acquisition: a negative outcome, -28.9%
On July 8, 2026, Chemomab Therapeutics Ltd. reached its Acquisition. The result was a negative outcome, and the stock moved -28.9% in the window around the event. It had already run +25.4% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.
The move
$2.77
1d before
$1.97
Event day
$1.83
1d after
$1.65
5d after
Our prediction vs. the result
CatalystAlert called this one neutral (+0.0% expected); the stock actually moved -28.9%. Model confidence at the time: 35%.
See the full scored track recordPre-catalyst setup
+25.4%
30-day run-up
14047%
30-day volatility
2.4×
volume spike